Cargando…
BRAF mutation correlates with worse local–regional control following radiation therapy in patients with stage III melanoma
BACKGROUND: In patients with stage III melanoma, the use of adjuvant radiation therapy (RT) after lymph node dissection (LND) may be currently considered in selected high-risk patients to improve tumor control. Melanomas harbor BRAF mutations (BRAF+) in 40–50% of cases, the majority of which are on...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449455/ https://www.ncbi.nlm.nih.gov/pubmed/34537078 http://dx.doi.org/10.1186/s13014-021-01903-5 |